nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Pimecrolimus—atopic dermatitis	0.146	0.258	CbGbCtD
Conivaptan—CYP3A4—Tacrolimus—atopic dermatitis	0.0871	0.153	CbGbCtD
Conivaptan—CYP3A4—Loratadine—atopic dermatitis	0.0637	0.112	CbGbCtD
Conivaptan—CYP3A4—Methylprednisolone—atopic dermatitis	0.0583	0.103	CbGbCtD
Conivaptan—CYP3A4—Triamcinolone—atopic dermatitis	0.0442	0.0778	CbGbCtD
Conivaptan—CYP3A4—Betamethasone—atopic dermatitis	0.0379	0.0668	CbGbCtD
Conivaptan—CYP3A4—Prednisolone—atopic dermatitis	0.0374	0.0659	CbGbCtD
Conivaptan—CYP3A4—Hydrocortisone—atopic dermatitis	0.0354	0.0624	CbGbCtD
Conivaptan—CYP3A4—Prednisone—atopic dermatitis	0.0353	0.0622	CbGbCtD
Conivaptan—CYP3A4—Dexamethasone—atopic dermatitis	0.022	0.0388	CbGbCtD
Conivaptan—AVPR1A—Peptide GPCRs—CCR3—atopic dermatitis	0.00378	0.023	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—CCR3—atopic dermatitis	0.00375	0.0228	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00338	0.0206	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00336	0.0204	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide GPCRs—CXCR3—atopic dermatitis	0.0033	0.0201	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—CXCR3—atopic dermatitis	0.00328	0.02	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00302	0.0184	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00299	0.0182	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.0027	0.0165	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00269	0.0163	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00227	0.0138	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00225	0.0137	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—NPS—atopic dermatitis	0.00221	0.0135	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00218	0.0133	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00216	0.0132	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide GPCRs—CCR5—atopic dermatitis	0.00207	0.0126	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00206	0.0125	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—CCR5—atopic dermatitis	0.00206	0.0125	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00202	0.0123	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00201	0.0122	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00181	0.011	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.0018	0.011	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00178	0.0108	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00176	0.0107	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL22—atopic dermatitis	0.00173	0.0105	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL22—atopic dermatitis	0.00172	0.0104	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—TAC1—atopic dermatitis	0.0016	0.00976	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—NPS—atopic dermatitis	0.0016	0.00976	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00158	0.00964	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00158	0.00964	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00157	0.00957	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00157	0.00957	CbGpPWpGaD
Conivaptan—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00157	0.00586	CcSEcCtD
Conivaptan—Infestation NOS—Fluocinolone Acetonide—atopic dermatitis	0.00157	0.00584	CcSEcCtD
Conivaptan—Infestation—Fluocinolone Acetonide—atopic dermatitis	0.00157	0.00584	CcSEcCtD
Conivaptan—Skin disorder—Fluocinonide—atopic dermatitis	0.00155	0.0058	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00155	0.00945	CbGpPWpGaD
Conivaptan—Hyponatraemia—Tacrolimus—atopic dermatitis	0.00155	0.00579	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00154	0.00939	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL27—atopic dermatitis	0.00154	0.00937	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL27—atopic dermatitis	0.00153	0.00931	CbGpPWpGaD
Conivaptan—Dry mouth—Diphenhydramine—atopic dermatitis	0.00147	0.00549	CcSEcCtD
Conivaptan—Dry mouth—Dimenhydrinate—atopic dermatitis	0.00147	0.00549	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00146	0.0089	CbGpPWpGaD
Conivaptan—Confusional state—Diphenhydramine—atopic dermatitis	0.00146	0.00543	CcSEcCtD
Conivaptan—Confusional state—Dimenhydrinate—atopic dermatitis	0.00146	0.00543	CcSEcCtD
Conivaptan—Urinary tract infection—Mometasone—atopic dermatitis	0.00145	0.00542	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00145	0.00884	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Pimecrolimus—atopic dermatitis	0.00145	0.00539	CcSEcCtD
Conivaptan—Dehydration—Tacrolimus—atopic dermatitis	0.00144	0.00536	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00144	0.00873	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00144	0.00873	CbGpPWpGaD
Conivaptan—Orthostatic hypotension—Tacrolimus—atopic dermatitis	0.00141	0.00526	CcSEcCtD
Conivaptan—Hypokalaemia—Tacrolimus—atopic dermatitis	0.00141	0.00525	CcSEcCtD
Conivaptan—Pruritus—Desonide—atopic dermatitis	0.0014	0.00522	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00139	0.00847	CbGpPWpGaD
Conivaptan—Infection—Pimecrolimus—atopic dermatitis	0.00139	0.00517	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCL17—atopic dermatitis	0.00138	0.00841	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00138	0.00841	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL17—atopic dermatitis	0.00137	0.00835	CbGpPWpGaD
Conivaptan—Pain—Fluocinonide—atopic dermatitis	0.00137	0.00511	CcSEcCtD
Conivaptan—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00137	0.00511	CcSEcCtD
Conivaptan—Skin disorder—Pimecrolimus—atopic dermatitis	0.00136	0.00506	CcSEcCtD
Conivaptan—Hypotension—Dimenhydrinate—atopic dermatitis	0.00135	0.00503	CcSEcCtD
Conivaptan—Hypotension—Diphenhydramine—atopic dermatitis	0.00135	0.00503	CcSEcCtD
Conivaptan—Insomnia—Dimenhydrinate—atopic dermatitis	0.00131	0.00487	CcSEcCtD
Conivaptan—Insomnia—Diphenhydramine—atopic dermatitis	0.00131	0.00487	CcSEcCtD
Conivaptan—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00127	0.00473	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00126	0.00764	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00125	0.00759	CbGpPWpGaD
Conivaptan—Headache—Desonide—atopic dermatitis	0.00124	0.00462	CcSEcCtD
Conivaptan—Constipation—Dimenhydrinate—atopic dermatitis	0.00123	0.00461	CcSEcCtD
Conivaptan—Constipation—Diphenhydramine—atopic dermatitis	0.00123	0.00461	CcSEcCtD
Conivaptan—Pollakiuria—Tacrolimus—atopic dermatitis	0.00123	0.0046	CcSEcCtD
Conivaptan—Mental disorder—Fluocinolone Acetonide—atopic dermatitis	0.00123	0.0046	CcSEcCtD
Conivaptan—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00122	0.00457	CcSEcCtD
Conivaptan—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.00122	0.00457	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00122	0.0074	CbGpPWpGaD
Conivaptan—Mediastinal disorder—Mometasone—atopic dermatitis	0.00121	0.00452	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00121	0.00735	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.0012	0.0045	CcSEcCtD
Conivaptan—Hyperglycaemia—Tacrolimus—atopic dermatitis	0.0012	0.00449	CcSEcCtD
Conivaptan—Pneumonia—Tacrolimus—atopic dermatitis	0.0012	0.00447	CcSEcCtD
Conivaptan—Pain—Pimecrolimus—atopic dermatitis	0.00119	0.00445	CcSEcCtD
Conivaptan—Constipation—Pimecrolimus—atopic dermatitis	0.00119	0.00445	CcSEcCtD
Conivaptan—Candida infection—Triamcinolone—atopic dermatitis	0.00119	0.00445	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00119	0.00726	CbGpPWpGaD
Conivaptan—Infestation NOS—Tacrolimus—atopic dermatitis	0.00119	0.00444	CcSEcCtD
Conivaptan—Infestation—Tacrolimus—atopic dermatitis	0.00119	0.00444	CcSEcCtD
Conivaptan—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00119	0.00444	CcSEcCtD
Conivaptan—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00119	0.00444	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00118	0.0072	CbGpPWpGaD
Conivaptan—Hypertension—Loratadine—atopic dermatitis	0.00118	0.00439	CcSEcCtD
Conivaptan—Urinary tract infection—Tacrolimus—atopic dermatitis	0.00116	0.00432	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.00115	0.0043	CcSEcCtD
Conivaptan—Haematuria—Tacrolimus—atopic dermatitis	0.00113	0.00424	CcSEcCtD
Conivaptan—Dry mouth—Loratadine—atopic dermatitis	0.00113	0.00423	CcSEcCtD
Conivaptan—Pruritus—Fluocinonide—atopic dermatitis	0.00113	0.00423	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCL11—atopic dermatitis	0.00111	0.00678	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL11—atopic dermatitis	0.00111	0.00673	CbGpPWpGaD
Conivaptan—Body temperature increased—Pimecrolimus—atopic dermatitis	0.0011	0.00412	CcSEcCtD
Conivaptan—Nervous system disorder—Loratadine—atopic dermatitis	0.00109	0.00407	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00108	0.00658	CbGpPWpGaD
Conivaptan—Skin disorder—Loratadine—atopic dermatitis	0.00108	0.00403	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00107	0.00653	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00106	0.00647	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00106	0.00647	CbGpPWpGaD
Conivaptan—Urinary tract disorder—Tacrolimus—atopic dermatitis	0.00106	0.00394	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00105	0.00642	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00105	0.00642	CbGpPWpGaD
Conivaptan—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00105	0.00393	CcSEcCtD
Conivaptan—Urethral disorder—Tacrolimus—atopic dermatitis	0.00105	0.00391	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00104	0.00634	CbGpPWpGaD
Conivaptan—Hypotension—Loratadine—atopic dermatitis	0.00104	0.00388	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00103	0.0063	CbGpPWpGaD
Conivaptan—Insomnia—Loratadine—atopic dermatitis	0.00101	0.00375	CcSEcCtD
Conivaptan—Headache—Fluocinonide—atopic dermatitis	0.001	0.00374	CcSEcCtD
Conivaptan—Infection—Fluocinolone Acetonide—atopic dermatitis	0.000992	0.0037	CcSEcCtD
Conivaptan—Cardiac disorder—Tacrolimus—atopic dermatitis	0.000992	0.0037	CcSEcCtD
Conivaptan—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000987	0.00368	CcSEcCtD
Conivaptan—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000987	0.00368	CcSEcCtD
Conivaptan—Cardiac failure—Hydrocortisone—atopic dermatitis	0.000987	0.00368	CcSEcCtD
Conivaptan—Pruritus—Pimecrolimus—atopic dermatitis	0.000987	0.00368	CcSEcCtD
Conivaptan—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00098	0.00366	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000974	0.00593	CbGpPWpGaD
Conivaptan—Dry mouth—Mometasone—atopic dermatitis	0.000973	0.00363	CcSEcCtD
Conivaptan—Angiopathy—Tacrolimus—atopic dermatitis	0.000969	0.00362	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000967	0.00588	CbGpPWpGaD
Conivaptan—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.000963	0.00359	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00096	0.00358	CcSEcCtD
Conivaptan—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000955	0.00356	CcSEcCtD
Conivaptan—Pain—Loratadine—atopic dermatitis	0.00095	0.00355	CcSEcCtD
Conivaptan—Constipation—Loratadine—atopic dermatitis	0.00095	0.00355	CcSEcCtD
Conivaptan—Infection—Mometasone—atopic dermatitis	0.000948	0.00354	CcSEcCtD
Conivaptan—Mental disorder—Tacrolimus—atopic dermatitis	0.000936	0.00349	CcSEcCtD
Conivaptan—Erythema—Tacrolimus—atopic dermatitis	0.00093	0.00347	CcSEcCtD
Conivaptan—Malnutrition—Tacrolimus—atopic dermatitis	0.00093	0.00347	CcSEcCtD
Conivaptan—Cardiac failure—Methylprednisolone—atopic dermatitis	0.000928	0.00346	CcSEcCtD
Conivaptan—Vomiting—Dimenhydrinate—atopic dermatitis	0.000918	0.00342	CcSEcCtD
Conivaptan—Vomiting—Diphenhydramine—atopic dermatitis	0.000918	0.00342	CcSEcCtD
Conivaptan—Feeling abnormal—Loratadine—atopic dermatitis	0.000916	0.00342	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCR3—atopic dermatitis	0.000908	0.00552	CbGpPWpGaD
Conivaptan—Headache—Diphenhydramine—atopic dermatitis	0.000904	0.00337	CcSEcCtD
Conivaptan—Headache—Dimenhydrinate—atopic dermatitis	0.000904	0.00337	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CCR3—atopic dermatitis	0.000901	0.00549	CbGpPWpGaD
Conivaptan—Vomiting—Pimecrolimus—atopic dermatitis	0.000887	0.00331	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCL22—atopic dermatitis	0.000887	0.0054	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL22—atopic dermatitis	0.000881	0.00536	CbGpPWpGaD
Conivaptan—Body temperature increased—Loratadine—atopic dermatitis	0.000879	0.00328	CcSEcCtD
Conivaptan—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.000877	0.00327	CcSEcCtD
Conivaptan—Headache—Pimecrolimus—atopic dermatitis	0.000874	0.00326	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000871	0.0053	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.000864	0.00526	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000862	0.00322	CcSEcCtD
Conivaptan—Anaemia—Tacrolimus—atopic dermatitis	0.00086	0.00321	CcSEcCtD
Conivaptan—Nausea—Diphenhydramine—atopic dermatitis	0.000857	0.0032	CcSEcCtD
Conivaptan—Nausea—Dimenhydrinate—atopic dermatitis	0.000857	0.0032	CcSEcCtD
Conivaptan—Sepsis—Prednisone—atopic dermatitis	0.000857	0.0032	CcSEcCtD
Conivaptan—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000854	0.00319	CcSEcCtD
Conivaptan—Cardiac failure—Betamethasone—atopic dermatitis	0.000844	0.00315	CcSEcCtD
Conivaptan—Cardiac failure—Dexamethasone—atopic dermatitis	0.000844	0.00315	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000842	0.00513	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000836	0.00509	CbGpPWpGaD
Conivaptan—Nausea—Pimecrolimus—atopic dermatitis	0.000829	0.00309	CcSEcCtD
Conivaptan—Pain—Mometasone—atopic dermatitis	0.000816	0.00304	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—TAC1—atopic dermatitis	0.000809	0.00492	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—NPS—atopic dermatitis	0.000809	0.00492	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—NPS—atopic dermatitis	0.000803	0.00489	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—TAC1—atopic dermatitis	0.000803	0.00489	CbGpPWpGaD
Conivaptan—Hypertension—Tacrolimus—atopic dermatitis	0.000803	0.003	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CXCR3—atopic dermatitis	0.000794	0.00483	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL27—atopic dermatitis	0.000791	0.00481	CbGpPWpGaD
Conivaptan—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.00079	0.00295	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.000788	0.00479	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000786	0.00293	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCL27—atopic dermatitis	0.000785	0.00478	CbGpPWpGaD
Conivaptan—Dry mouth—Tacrolimus—atopic dermatitis	0.000774	0.00289	CcSEcCtD
Conivaptan—Confusional state—Tacrolimus—atopic dermatitis	0.000765	0.00286	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000762	0.00464	CbGpPWpGaD
Conivaptan—Diarrhoea—Loratadine—atopic dermatitis	0.00076	0.00284	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000757	0.00461	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000757	0.0046	CbGpPWpGaD
Conivaptan—Infection—Tacrolimus—atopic dermatitis	0.000754	0.00281	CcSEcCtD
Conivaptan—Body temperature increased—Mometasone—atopic dermatitis	0.000754	0.00281	CcSEcCtD
Conivaptan—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000749	0.0028	CcSEcCtD
Conivaptan—Hypokalaemia—Betamethasone—atopic dermatitis	0.000749	0.0028	CcSEcCtD
Conivaptan—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000744	0.00278	CcSEcCtD
Conivaptan—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000743	0.00277	CcSEcCtD
Conivaptan—Infestation—Hydrocortisone—atopic dermatitis	0.000743	0.00277	CcSEcCtD
Conivaptan—Skin disorder—Tacrolimus—atopic dermatitis	0.000737	0.00275	CcSEcCtD
Conivaptan—Cardiac failure—Prednisone—atopic dermatitis	0.000735	0.00274	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000725	0.00441	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00072	0.00438	CbGpPWpGaD
Conivaptan—Hypotension—Tacrolimus—atopic dermatitis	0.000709	0.00265	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCL17—atopic dermatitis	0.000709	0.00431	CbGpPWpGaD
Conivaptan—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000707	0.00264	CcSEcCtD
Conivaptan—Vomiting—Loratadine—atopic dermatitis	0.000707	0.00264	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCL17—atopic dermatitis	0.000704	0.00428	CbGpPWpGaD
Conivaptan—Infestation—Methylprednisolone—atopic dermatitis	0.000698	0.0026	CcSEcCtD
Conivaptan—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000698	0.0026	CcSEcCtD
Conivaptan—Headache—Loratadine—atopic dermatitis	0.000696	0.0026	CcSEcCtD
Conivaptan—Insomnia—Tacrolimus—atopic dermatitis	0.000687	0.00256	CcSEcCtD
Conivaptan—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000683	0.00255	CcSEcCtD
Conivaptan—Pruritus—Mometasone—atopic dermatitis	0.000675	0.00252	CcSEcCtD
Conivaptan—Nausea—Loratadine—atopic dermatitis	0.00066	0.00246	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000655	0.00245	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000653	0.00398	CbGpPWpGaD
Conivaptan—Diarrhoea—Mometasone—atopic dermatitis	0.000653	0.00244	CcSEcCtD
Conivaptan—Hypokalaemia—Prednisone—atopic dermatitis	0.000652	0.00243	CcSEcCtD
Conivaptan—Pain—Tacrolimus—atopic dermatitis	0.000649	0.00242	CcSEcCtD
Conivaptan—Constipation—Tacrolimus—atopic dermatitis	0.000649	0.00242	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000649	0.00395	CbGpPWpGaD
Conivaptan—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000642	0.0024	CcSEcCtD
Conivaptan—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000642	0.0024	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL10—atopic dermatitis	0.000641	0.0039	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000637	0.00388	CbGpPWpGaD
Conivaptan—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000635	0.00237	CcSEcCtD
Conivaptan—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000626	0.00234	CcSEcCtD
Conivaptan—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000626	0.00233	CcSEcCtD
Conivaptan—Vomiting—Mometasone—atopic dermatitis	0.000606	0.00226	CcSEcCtD
Conivaptan—Body temperature increased—Tacrolimus—atopic dermatitis	0.0006	0.00224	CcSEcCtD
Conivaptan—Headache—Mometasone—atopic dermatitis	0.000598	0.00223	CcSEcCtD
Conivaptan—Erythema—Prednisolone—atopic dermatitis	0.000594	0.00222	CcSEcCtD
Conivaptan—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000593	0.00221	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000589	0.00358	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000585	0.00356	CbGpPWpGaD
Conivaptan—Mental disorder—Hydrocortisone—atopic dermatitis	0.000584	0.00218	CcSEcCtD
Conivaptan—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000581	0.00217	CcSEcCtD
Conivaptan—Malnutrition—Hydrocortisone—atopic dermatitis	0.00058	0.00217	CcSEcCtD
Conivaptan—Erythema—Hydrocortisone—atopic dermatitis	0.00058	0.00217	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCL11—atopic dermatitis	0.000572	0.00348	CbGpPWpGaD
Conivaptan—Angiopathy—Methylprednisolone—atopic dermatitis	0.000568	0.00212	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCL11—atopic dermatitis	0.000567	0.00345	CbGpPWpGaD
Conivaptan—Nausea—Mometasone—atopic dermatitis	0.000567	0.00211	CcSEcCtD
Conivaptan—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000564	0.00211	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—FCER2—atopic dermatitis	0.000564	0.00343	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FCER2—atopic dermatitis	0.00056	0.0034	CbGpPWpGaD
Conivaptan—Hyperglycaemia—Prednisone—atopic dermatitis	0.000559	0.00209	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCL5—atopic dermatitis	0.000552	0.00336	CbGpPWpGaD
Conivaptan—Mental disorder—Methylprednisolone—atopic dermatitis	0.000549	0.00205	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CCL5—atopic dermatitis	0.000548	0.00334	CbGpPWpGaD
Conivaptan—Erythema—Triamcinolone—atopic dermatitis	0.000546	0.00204	CcSEcCtD
Conivaptan—Erythema—Methylprednisolone—atopic dermatitis	0.000545	0.00203	CcSEcCtD
Conivaptan—Malnutrition—Methylprednisolone—atopic dermatitis	0.000545	0.00203	CcSEcCtD
Conivaptan—Pruritus—Tacrolimus—atopic dermatitis	0.000537	0.002	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCL22—atopic dermatitis	0.000524	0.00319	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL22—atopic dermatitis	0.00052	0.00317	CbGpPWpGaD
Conivaptan—Diarrhoea—Tacrolimus—atopic dermatitis	0.000519	0.00194	CcSEcCtD
Conivaptan—Angiopathy—Dexamethasone—atopic dermatitis	0.000517	0.00193	CcSEcCtD
Conivaptan—Angiopathy—Betamethasone—atopic dermatitis	0.000517	0.00193	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000513	0.00312	CbGpPWpGaD
Conivaptan—Hypertension—Prednisolone—atopic dermatitis	0.000513	0.00191	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000509	0.0031	CbGpPWpGaD
Conivaptan—Hypertension—Hydrocortisone—atopic dermatitis	0.000501	0.00187	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCR5—atopic dermatitis	0.000497	0.00303	CbGpPWpGaD
Conivaptan—Erythema—Dexamethasone—atopic dermatitis	0.000496	0.00185	CcSEcCtD
Conivaptan—Erythema—Betamethasone—atopic dermatitis	0.000496	0.00185	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000494	0.00301	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000491	0.00183	CcSEcCtD
Conivaptan—Vomiting—Tacrolimus—atopic dermatitis	0.000483	0.0018	CcSEcCtD
Conivaptan—Headache—Tacrolimus—atopic dermatitis	0.000476	0.00177	CcSEcCtD
Conivaptan—Hypertension—Triamcinolone—atopic dermatitis	0.000472	0.00176	CcSEcCtD
Conivaptan—Hypertension—Methylprednisolone—atopic dermatitis	0.000471	0.00176	CcSEcCtD
Conivaptan—Infection—Hydrocortisone—atopic dermatitis	0.00047	0.00176	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCL27—atopic dermatitis	0.000467	0.00284	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR3—atopic dermatitis	0.000466	0.00284	CbGpPWpGaD
Conivaptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000464	0.00173	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—CCL27—atopic dermatitis	0.000464	0.00282	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000463	0.00281	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000461	0.00172	CcSEcCtD
Conivaptan—Skin disorder—Hydrocortisone—atopic dermatitis	0.00046	0.00172	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—NPS—atopic dermatitis	0.000457	0.00278	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000457	0.00278	CbGpPWpGaD
Conivaptan—Dry mouth—Triamcinolone—atopic dermatitis	0.000455	0.0017	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000454	0.00276	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000454	0.00276	CbGpPWpGaD
Conivaptan—Nausea—Tacrolimus—atopic dermatitis	0.000451	0.00168	CcSEcCtD
Conivaptan—Angiopathy—Prednisone—atopic dermatitis	0.00045	0.00168	CcSEcCtD
Conivaptan—Confusional state—Methylprednisolone—atopic dermatitis	0.000449	0.00167	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000448	0.00273	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000445	0.00271	CbGpPWpGaD
Conivaptan—Infection—Triamcinolone—atopic dermatitis	0.000443	0.00165	CcSEcCtD
Conivaptan—Hypotension—Hydrocortisone—atopic dermatitis	0.000443	0.00165	CcSEcCtD
Conivaptan—Infection—Methylprednisolone—atopic dermatitis	0.000442	0.00165	CcSEcCtD
Conivaptan—Insomnia—Prednisolone—atopic dermatitis	0.000439	0.00164	CcSEcCtD
Conivaptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000436	0.00163	CcSEcCtD
Conivaptan—Mental disorder—Prednisone—atopic dermatitis	0.000435	0.00162	CcSEcCtD
Conivaptan—Skin disorder—Methylprednisolone—atopic dermatitis	0.000432	0.00161	CcSEcCtD
Conivaptan—Malnutrition—Prednisone—atopic dermatitis	0.000432	0.00161	CcSEcCtD
Conivaptan—Erythema—Prednisone—atopic dermatitis	0.000432	0.00161	CcSEcCtD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000431	0.00262	CbGpPWpGaD
Conivaptan—Insomnia—Hydrocortisone—atopic dermatitis	0.000428	0.0016	CcSEcCtD
Conivaptan—Hypertension—Betamethasone—atopic dermatitis	0.000428	0.0016	CcSEcCtD
Conivaptan—Hypertension—Dexamethasone—atopic dermatitis	0.000428	0.0016	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—IL5—atopic dermatitis	0.000425	0.00259	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000422	0.00257	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL17—atopic dermatitis	0.000419	0.00255	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL17—atopic dermatitis	0.000416	0.00253	CbGpPWpGaD
Conivaptan—Hypotension—Methylprednisolone—atopic dermatitis	0.000416	0.00155	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—TAC1—atopic dermatitis	0.000415	0.00253	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPS—atopic dermatitis	0.000415	0.00253	CbGpPWpGaD
Conivaptan—Pain—Prednisolone—atopic dermatitis	0.000415	0.00155	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000412	0.00251	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPS—atopic dermatitis	0.000412	0.00251	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000409	0.00153	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000407	0.00248	CbGpPWpGaD
Conivaptan—Pain—Hydrocortisone—atopic dermatitis	0.000405	0.00151	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000404	0.00246	CbGpPWpGaD
Conivaptan—Insomnia—Triamcinolone—atopic dermatitis	0.000403	0.00151	CcSEcCtD
Conivaptan—Insomnia—Methylprednisolone—atopic dermatitis	0.000402	0.0015	CcSEcCtD
Conivaptan—Infection—Dexamethasone—atopic dermatitis	0.000402	0.0015	CcSEcCtD
Conivaptan—Infection—Betamethasone—atopic dermatitis	0.000402	0.0015	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisolone—atopic dermatitis	0.0004	0.00149	CcSEcCtD
Conivaptan—Anaemia—Prednisone—atopic dermatitis	0.000399	0.00149	CcSEcCtD
Conivaptan—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000397	0.00148	CcSEcCtD
Conivaptan—Nervous system disorder—Betamethasone—atopic dermatitis	0.000397	0.00148	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000395	0.0024	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000392	0.00239	CbGpPWpGaD
Conivaptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.00039	0.00146	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—IL5—atopic dermatitis	0.000386	0.00235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL5—atopic dermatitis	0.000383	0.00233	CbGpPWpGaD
Conivaptan—Pain—Triamcinolone—atopic dermatitis	0.000381	0.00142	CcSEcCtD
Conivaptan—Hypotension—Dexamethasone—atopic dermatitis	0.000378	0.00141	CcSEcCtD
Conivaptan—Hypotension—Betamethasone—atopic dermatitis	0.000378	0.00141	CcSEcCtD
Conivaptan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000374	0.0014	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—KIF3A—atopic dermatitis	0.000373	0.00227	CbGpPWpGaD
Conivaptan—Hypertension—Prednisone—atopic dermatitis	0.000373	0.00139	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000371	0.00226	CbGpPWpGaD
Conivaptan—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000367	0.00137	CcSEcCtD
Conivaptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000367	0.00137	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000367	0.00223	CbGpPWpGaD
Conivaptan—Insomnia—Betamethasone—atopic dermatitis	0.000366	0.00137	CcSEcCtD
Conivaptan—Insomnia—Dexamethasone—atopic dermatitis	0.000366	0.00137	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000365	0.00136	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000362	0.00221	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00036	0.00219	CbGpPWpGaD
Conivaptan—Body temperature increased—Triamcinolone—atopic dermatitis	0.000353	0.00132	CcSEcCtD
Conivaptan—Infection—Prednisone—atopic dermatitis	0.00035	0.00131	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000349	0.0013	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000349	0.0013	CcSEcCtD
Conivaptan—Pain—Betamethasone—atopic dermatitis	0.000346	0.00129	CcSEcCtD
Conivaptan—Pain—Dexamethasone—atopic dermatitis	0.000346	0.00129	CcSEcCtD
Conivaptan—Nervous system disorder—Prednisone—atopic dermatitis	0.000346	0.00129	CcSEcCtD
Conivaptan—Skin disorder—Prednisone—atopic dermatitis	0.000342	0.00128	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CMA1—atopic dermatitis	0.000338	0.00205	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL11—atopic dermatitis	0.000338	0.00205	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CMA1—atopic dermatitis	0.000335	0.00204	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL11—atopic dermatitis	0.000335	0.00204	CbGpPWpGaD
Conivaptan—Pruritus—Hydrocortisone—atopic dermatitis	0.000335	0.00125	CcSEcCtD
Conivaptan—Feeling abnormal—Betamethasone—atopic dermatitis	0.000333	0.00124	CcSEcCtD
Conivaptan—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000333	0.00124	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000329	0.002	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000327	0.00199	CbGpPWpGaD
Conivaptan—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000324	0.00121	CcSEcCtD
Conivaptan—Body temperature increased—Dexamethasone—atopic dermatitis	0.00032	0.00119	CcSEcCtD
Conivaptan—Body temperature increased—Betamethasone—atopic dermatitis	0.00032	0.00119	CcSEcCtD
Conivaptan—Insomnia—Prednisone—atopic dermatitis	0.000319	0.00119	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—STAT6—atopic dermatitis	0.000317	0.00193	CbGpPWpGaD
Conivaptan—Pruritus—Triamcinolone—atopic dermatitis	0.000315	0.00118	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—STAT6—atopic dermatitis	0.000315	0.00192	CbGpPWpGaD
Conivaptan—Pruritus—Methylprednisolone—atopic dermatitis	0.000315	0.00117	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000312	0.0019	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.00031	0.00189	CbGpPWpGaD
Conivaptan—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000304	0.00114	CcSEcCtD
Conivaptan—Headache—Prednisolone—atopic dermatitis	0.000304	0.00113	CcSEcCtD
Conivaptan—Constipation—Prednisone—atopic dermatitis	0.000301	0.00112	CcSEcCtD
Conivaptan—Vomiting—Hydrocortisone—atopic dermatitis	0.000301	0.00112	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000301	0.00183	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.0003	0.00182	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000299	0.00182	CbGpPWpGaD
Conivaptan—Headache—Hydrocortisone—atopic dermatitis	0.000297	0.00111	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisone—atopic dermatitis	0.00029	0.00108	CcSEcCtD
Conivaptan—Nausea—Prednisolone—atopic dermatitis	0.000288	0.00107	CcSEcCtD
Conivaptan—Pruritus—Betamethasone—atopic dermatitis	0.000286	0.00107	CcSEcCtD
Conivaptan—Pruritus—Dexamethasone—atopic dermatitis	0.000286	0.00107	CcSEcCtD
Conivaptan—Vomiting—Triamcinolone—atopic dermatitis	0.000284	0.00106	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCL5—atopic dermatitis	0.000283	0.00172	CbGpPWpGaD
Conivaptan—Vomiting—Methylprednisolone—atopic dermatitis	0.000283	0.00106	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000281	0.00171	CbGpPWpGaD
Conivaptan—Nausea—Hydrocortisone—atopic dermatitis	0.000281	0.00105	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000281	0.00171	CbGpPWpGaD
Conivaptan—Headache—Triamcinolone—atopic dermatitis	0.000279	0.00104	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000279	0.0017	CbGpPWpGaD
Conivaptan—Headache—Methylprednisolone—atopic dermatitis	0.000279	0.00104	CcSEcCtD
Conivaptan—Body temperature increased—Prednisone—atopic dermatitis	0.000279	0.00104	CcSEcCtD
Conivaptan—Diarrhoea—Dexamethasone—atopic dermatitis	0.000277	0.00103	CcSEcCtD
Conivaptan—Diarrhoea—Betamethasone—atopic dermatitis	0.000277	0.00103	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCR3—atopic dermatitis	0.000275	0.00167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR3—atopic dermatitis	0.000273	0.00166	CbGpPWpGaD
Conivaptan—Nausea—Triamcinolone—atopic dermatitis	0.000265	0.000988	CcSEcCtD
Conivaptan—Nausea—Methylprednisolone—atopic dermatitis	0.000264	0.000986	CcSEcCtD
Conivaptan—Vomiting—Betamethasone—atopic dermatitis	0.000257	0.00096	CcSEcCtD
Conivaptan—Vomiting—Dexamethasone—atopic dermatitis	0.000257	0.00096	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCR5—atopic dermatitis	0.000255	0.00155	CbGpPWpGaD
Conivaptan—Headache—Dexamethasone—atopic dermatitis	0.000253	0.000946	CcSEcCtD
Conivaptan—Headache—Betamethasone—atopic dermatitis	0.000253	0.000946	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000253	0.00154	CbGpPWpGaD
Conivaptan—Pruritus—Prednisone—atopic dermatitis	0.000249	0.00093	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—TAC1—atopic dermatitis	0.000245	0.00149	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPS—atopic dermatitis	0.000245	0.00149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TAC1—atopic dermatitis	0.000244	0.00148	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPS—atopic dermatitis	0.000244	0.00148	CbGpPWpGaD
Conivaptan—Diarrhoea—Prednisone—atopic dermatitis	0.000241	0.0009	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CXCR3—atopic dermatitis	0.000241	0.00146	CbGpPWpGaD
Conivaptan—Nausea—Dexamethasone—atopic dermatitis	0.00024	0.000897	CcSEcCtD
Conivaptan—Nausea—Betamethasone—atopic dermatitis	0.00024	0.000897	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000239	0.00145	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL5—atopic dermatitis	0.000228	0.00139	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL5—atopic dermatitis	0.000226	0.00138	CbGpPWpGaD
Conivaptan—Vomiting—Prednisone—atopic dermatitis	0.000224	0.000836	CcSEcCtD
Conivaptan—Headache—Prednisone—atopic dermatitis	0.000221	0.000824	CcSEcCtD
Conivaptan—Nausea—Prednisone—atopic dermatitis	0.000209	0.000781	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CXCL10—atopic dermatitis	0.000194	0.00118	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000193	0.00117	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.00017	0.00103	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000169	0.00103	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—atopic dermatitis	0.000167	0.00102	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—atopic dermatitis	0.000166	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—atopic dermatitis	0.000162	0.000988	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—atopic dermatitis	0.000161	0.000981	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGF—atopic dermatitis	0.000155	0.000943	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—atopic dermatitis	0.000154	0.000939	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGF—atopic dermatitis	0.000154	0.000937	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000153	0.000932	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR5—atopic dermatitis	0.000151	0.000918	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR5—atopic dermatitis	0.00015	0.000911	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—atopic dermatitis	0.000147	0.000898	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—atopic dermatitis	0.000146	0.000891	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKBIA—atopic dermatitis	0.000128	0.000778	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000127	0.000772	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—atopic dermatitis	9.12e-05	0.000555	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—atopic dermatitis	9.05e-05	0.000551	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—atopic dermatitis	8.71e-05	0.00053	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—atopic dermatitis	8.67e-05	0.000528	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—atopic dermatitis	8.65e-05	0.000526	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—atopic dermatitis	8.61e-05	0.000524	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—atopic dermatitis	8.02e-05	0.000488	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—atopic dermatitis	7.96e-05	0.000485	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.21e-05	0.000378	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.95e-05	0.000362	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—atopic dermatitis	5.12e-05	0.000312	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—atopic dermatitis	5.08e-05	0.000309	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.01e-05	0.000123	CbGpPWpGaD
